Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients

Nephron

Volumn 90, Issue 3, 2002, Pages 282-289

  Małyszko, Jolanta ^a   Wołczyński, Sławomir ^a   Zbroch, Edyta ^a   Brzósko, Szymon ^a   Małyszko, Jacek ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Continuous ambulatory peritoneal dialysis; Erythropoietin; Hemodialysis; IGFBP 1; IGFBP 3; Insulin growth factor 1; Kidney transplantation

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CHOLESTEROL; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN C PROTEINASE; RECOMBINANT ERYTHROPOIETIN; SOMATOMEDIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BIOASSAY; BONE METABOLISM; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUTRITION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; RADIOIMMUNOASSAY; RECIPIENT; RENAL OSTEODYSTROPHY;

ADULT; AGED; BONE AND BONES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0036190882     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049064     Document Type: Article

References (28)

1. New concepts in renal osteodystrophy
2. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor 1 gene expression in ovariectomized rats
3. Insulin-like growth factor binding proteins in bone cell regulation
4. Effect of tumor necrosis factor-alpha on the expression insulin-like growth factor 1 and insulin-like growth factor binding protein 4 in mouse osteoblasts
5. Insulin-like growth factors system components: The osteoporosis connection
6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
7. Insulin-like growth factor I and erythropoiesis
8. Subtherapeutic erythropoetin and insulin-like growth factor I correct the anemia of chronic renal failure in the mouse
9. Roles of erythropoietin, insulin-like growth factor I, and unidentified factors in promoting maturation of purified murine erythroid colony-forming units
10. Poor response to erythropoietin: Practical guidelines on investigation and management
11. Erythropoietin, aluminium and anaemia in patients on haemodialysis
12. Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins
13. Analytical methods for aluminium measurements
14. Insulin-like growth factors and their binding proteins: Biological actions
15. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGFs
16. Serum insulin-like growth factor-I and binding proteins (IGF BP-1 and IGF BP-3) concentrations after renal transplantation in adults
17. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum
18. Corticosteroid-induced osteoporosis
19. Glucocorticoid-induced osteoporosis: Pathogenesis and management
20. Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study
21. Bone disease in patients with long-term renal transplantation and normal renal function
22. Bone disease in long-term renal transplantation: Histopathology and densitometry analysis
23. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
24. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation
25. Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis
26. Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion
27. Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts
28. Lack of influence of recombinant human erythropoietin on parathyroid function in hemodialysis patients with secondary hyperparathyroidism